Aid organizations must do more to secure drug safety and quality in developing countries
2008-11-19 메디칼라이터팀
Roger Bate, the director of the health advocacy group Africa Fighting Malaria, says, in an op-ed in the New York Times, that more must be done to secure the safety and quality of drugs in developing countries. Many poor governments have turned to local production, which is of low-quality. Most of them don’t have regulation to monitor safety nor laws against selling substandard drugs. Aid organizations must promote efforts to maintain strict drug inspection standards, refuse to subsidize any low-quality drugs and insist that only approved brand-name and generic products be distributed.